"Preferred Physicians Medical RRG","PNC QS","2024 09 30" Annual Statutory Statement
STATEMENT AS OF
ASSETS
Current Statement Date |
4 |
|||
1 |
2 |
3 |
|
|
Net Admitted Assets |
Prior Year Net |
|||
Assets |
Nonadmitted Assets |
(Cols. 1 - 2) |
Admitted Assets |
|
1. Bonds |
11,232,743 |
11,232,743 |
11,273,336 |
- Stocks:
-
- Preferred stocks
- Common stocks
- Mortgage loans on real estate:
-
- First liens
- Other than first liens
- Real estate:
-
- Properties occupied by the company (less
$ |
0 |
encumbrances) |
||||||
4.2 Properties held for the production of income |
||||||||
(less $ |
0 encumbrances) |
|||||||
4.3 Properties held for sale (less |
||||||||
$ |
0 |
encumbrances) |
||||||
5. |
Cash ($ |
(317,573) ), |
||||||
cash equivalents ($ |
1,878,937 |
) |
||||||
and short-term investments ($ |
0 |
) |
1,561,364 |
1,561,364 |
5,727,736 |
|||
6. |
Contract loans (including $ |
0 |
premium notes) |
- Derivatives
- Other invested assets
- Receivables for securities
- Securities lending reinvested collateral assets
- Aggregate write-ins for invested assets
12. |
Subtotals, cash and invested assets (Lines 1 to 11) |
12,794,107 |
12,794,107 |
17,001,072 |
|
13. |
Title plants less $ |
0 charged off (for Title insurers |
|||
only) |
|||||
14. |
Investment income due and accrued |
18,681 |
18,681 |
30,450 |
|
15. |
Premiums and considerations: |
||||
15.1 Uncollected premiums and agents' balances in the course of |
|||||
collection |
8,637,994 |
8,637,994 |
10,996,867 |
||
15.2 Deferred premiums, agents' balances and installments booked but |
|||||
deferred and not yet due (including $ |
0 earned |
||||
but unbilled premiums) |
|||||
15.3 Accrued retrospective premiums |
($ |
0 ) and |
|||
contracts subject to redetermination ($ |
0 ) |
||||
16. |
Reinsurance: |
||||
16.1 Amounts recoverable from reinsurers |
336,401 |
336,401 |
303,991 |
- Funds held by or deposited with reinsured companies
- Other amounts receivable under reinsurance contracts
17. Amounts receivable relating to uninsured plans
- Current federal and foreign income tax recoverable and interest thereon
- Net deferred tax asset
- Guaranty funds receivable or on deposit
- Electronic data processing equipment and software
- Furniture and equipment, including health care delivery assets
($ |
0 ) |
- Net adjustment in assets and liabilities due to foreign exchange rates
- Receivables from parent, subsidiaries and affiliates
24. Health care ($ |
0 ) and other amounts receivable |
- Aggregate write-ins for other-than-invested assets
- Total assets excluding Separate Accounts, Segregated Accounts and
Protected Cell Accounts (Lines 12 to 25) |
21,787,183 |
21,787,183 |
28,332,380 |
|
27. |
From Separate Accounts, Segregated Accounts and Protected |
|||
Cell Accounts |
||||
28. |
Total (Lines 26 and 27) |
21,787,183 |
21,787,183 |
28,332,380 |
DETAILS OF WRITE-INS
1101.
1102.
1103.
1198. Summary of remaining write-ins for Line 11 from overflow page
1199. Totals (Lines 1101 through 1103 plus 1198) (Line 11 above)
2501.
2502.
2503.
2598. Summary of remaining write-ins for Line 25 from overflow page
2599. Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)
2
STATEMENT AS OF
LIABILITIES, SURPLUS AND OTHER FUNDS
1 |
2 |
|||||
Current |
|
|||||
Statement Date |
Prior Year |
|||||
1. |
Losses (current accident year $ |
0 |
) |
|||
2. |
Reinsurance payable on paid losses and loss adjustment expenses |
|||||
3. |
Loss adjustment expenses |
3,200,561 |
3,200,561 |
|||
4. |
Commissions payable, contingent commissions and other similar charges |
|||||
5. |
Other expenses (excluding taxes, licenses and fees) |
769,678 |
1,566,401 |
|||
6. |
Taxes, licenses and fees (excluding federal and foreign income taxes) |
408,101 |
407,100 |
|||
7.1Current federal and foreign income taxes (including $ |
0 |
on realized capital gains (losses)) |
32,204 |
|||
7.2 Net deferred tax liability |
||||||
8. |
Borrowed money $ |
0 and interest thereon $ |
0 |
|||
9. |
Unearned premiums (after deducting unearned premiums for ceded reinsurance of $ |
21,717,815 and |
||||
including warranty reserves of $ |
0 and accrued accident and health experience rating refunds |
|||||
including $ |
0 for medical loss ratio rebate per the Public Health Service Act) |
|||||
10. |
Advance premium |
1,366,584 |
737,775 |
11. Dividends declared and unpaid:
- Stockholders
- Policyholders
12. |
Ceded reinsurance premiums payable (net of ceding commissions) |
9,853,288 |
16,085,148 |
|
13. |
Funds held by company under reinsurance treaties |
|||
14. |
Amounts withheld or retained by company for account of others |
195,449 |
258,974 |
|
15. |
Remittances and items not allocated |
|||
16. |
Provision for reinsurance (including $ |
0 certified) |
- Net adjustments in assets and liabilities due to foreign exchange rates
- Drafts outstanding
19. Payable to parent, subsidiaries and affiliates |
961,318 |
1,076,421 |
- Derivatives
- Payable for securities
- Payable for securities lending
- Liability for amounts held under uninsured plans
24. |
Capital notes $ |
0 and interest thereon $ |
0 |
|
25. |
Aggregate write-ins for liabilities |
|||
26. |
Total liabilities excluding protected cell liabilities (Lines 1 through 25) |
16,787,183 |
23,332,380 |
|
27. |
Protected cell liabilities |
|||
28. |
Total liabilities (Lines 26 and 27) |
16,787,183 |
23,332,380 |
- Aggregate write-ins for special surplus funds
- Common capital stock
- Preferred capital stock
- Aggregate write-ins for other than special surplus funds
33. Surplus notes |
5,000,000 |
5,000,000 |
- Gross paid in and contributed surplus
- Unassigned funds (surplus)
- Less treasury stock, at cost:
36.1 |
0 |
shares common (value included in Line 30 |
$ |
0 |
) |
|||
36.2 |
0 |
shares preferred (value included in Line 31 |
$ |
0 |
) |
|||
37. |
Surplus as regards policyholders (Lines 29 to 35, less 36) |
5,000,000 |
5,000,000 |
|||||
38. |
Totals (Page 2, Line 28, Col. 3) |
21,787,183 |
28,332,380 |
DETAILS OF WRITE-INS
2501.
2502.
2503.
2598. Summary of remaining write-ins for Line 25 from overflow page
2599. Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)
2901.
2902.
2903.
2998. Summary of remaining write-ins for Line 29 from overflow page
2999. Totals (Lines 2901 through 2903 plus 2998) (Line 29 above)
3201.
3202.
3203.
3298. Summary of remaining write-ins for Line 32 from overflow page
3299. Totals (Lines 3201 through 3203 plus 3298) (Line 32 above)
3
STATEMENT AS OF
STATEMENT OF INCOME
1 |
2 |
3 |
||||||
Current Year |
Prior Year |
Prior Year Ended |
||||||
to Date |
to Date |
|
||||||
1. |
Premiums earned: |
UNDERWRITING INCOME |
||||||
1.1 |
Direct (written $ |
21,157,542 |
) |
23,784,017 |
23,891,205 |
32,821,947 |
||
1.2 |
Assumed (written $ |
0 ) |
||||||
1.3 |
Ceded (written $ |
21,157,542 |
) |
23,784,017 |
23,891,205 |
32,821,947 |
||
1.4 |
Net (written $ |
0 |
) |
|||||
2. |
DEDUCTIONS: |
|||||||
Losses incurred (current accident year $ |
9,453,206 ): |
|||||||
2.1 Direct |
7,986,853 |
2,884,524 |
4,138,568 |
|||||
2.2 Assumed |
||||||||
2.3 Ceded |
7,986,853 |
2,884,524 |
4,138,568 |
|||||
3. |
2.4 Net |
|||||||
Loss adjustment expenses incurred |
1,628,263 |
1,720,166 |
2,037,396 |
|||||
4. |
Other underwriting expenses incurred |
(1,298,516) |
(1,366,030) |
(1,472,924) |
||||
5. |
Aggregate write-ins for underwriting deductions |
|||||||
6. |
Total underwriting deductions (Lines 2 through 5) |
329,747 |
354,136 |
564,472 |
||||
7. |
Net income of protected cells |
|||||||
8. |
Net underwriting gain (loss) (Line 1 minus Line 6 + Line 7) |
(329,747) |
(354,136) |
(564,472) |
||||
9. |
Net investment income earned |
INVESTMENT INCOME |
296,353 |
384,622 |
508,672 |
|||
10. |
Net realized capital gains (losses) less capital gains tax of $ |
0 |
||||||
11. |
Net investment gain (loss) (Lines 9 + 10) |
296,353 |
384,622 |
508,672 |
||||
12. |
OTHER INCOME |
|||||||
Net gain or (loss) from agents' or premium balances charged off |
||||||||
13. |
(amount recovered $ |
0 |
amount charged off $ |
0 ) |
||||
Finance and service charges not included in premiums |
||||||||
14. |
Aggregate write-ins for miscellaneous income |
65,598 |
74,608 |
|||||
15. |
Total other income (Lines 12 through 14) |
65,598 |
74,608 |
|||||
16. |
Net income before dividends to policyholders, after capital gains tax and before all other federal |
|||||||
and foreign income taxes (Lines 8 + 11 + 15) |
32,204 |
30,486 |
18,808 |
- Dividends to policyholders
- Net income, after dividends to policyholders, after capital gains tax and before all other federal
19. |
and foreign income taxes (Line 16 minus Line 17) |
32,204 |
30,486 |
18,808 |
Federal and foreign income taxes incurred |
32,204 |
30,486 |
18,808 |
|
20. |
Net income (Line 18 minus Line 19)(to Line 22) |
|||
21. |
CAPITAL AND SURPLUS ACCOUNT |
|||
Surplus as regards policyholders, |
5,000,000 |
5,000,000 |
5,000,000 |
- Net income (from Line 20)
- Net transfers (to) from Protected Cell accounts
- Change in net unrealized capital gains or (losses) less capital gains tax of
$0
- Change in net unrealized foreign exchange capital gain (loss)
- Change in net deferred income tax
- Change in nonadmitted assets
- Change in provision for reinsurance
- Change in surplus notes
- Surplus (contributed to) withdrawn from protected cells
- Cumulative effect of changes in accounting principles
- Capital changes:
-
- Paid in
- Transferred from surplus (Stock Dividend)
- Transferred to surplus
- Surplus adjustments:
-
- Paid in
- Transferred to capital (Stock Dividend)
- Transferred from capital
- Net remittances from or (to) Home Office
- Dividends to stockholders
- Change in treasury stock
- Aggregate write-ins for gains and losses in surplus
- Change in surplus as regards policyholders (Lines 22 through 37)
39. |
Surplus as regards policyholders, as of statement date (Lines 21 plus 38) |
5,000,000 |
5,000,000 |
5,000,000 |
0501. |
DETAILS OF WRITE-INS |
|||
0502. |
||||
0503. |
||||
0598. |
Summary of remaining write-ins for Line 5 from overflow page |
|||
0599. |
TOTALS (Lines 0501 through 0503 plus 0598) (Line 5 above) |
|||
1401. |
MIscellaneous Income |
65,598 |
74,608 |
|
1402. |
||||
1403. |
||||
1498. |
Summary of remaining write-ins for Line 14 from overflow page |
|||
1499. |
TOTALS (Lines 1401 through 1403 plus 1498) (Line 14 above) |
65,598 |
74,608 |
|
3701. |
||||
3702. |
||||
3703. |
||||
3798. |
Summary of remaining write-ins for Line 37 from overflow page |
|||
3799. |
TOTALS (Lines 3701 through 3703 plus 3798) (Line 37 above) |
4
STATEMENT AS OF
CASH FLOW
1 |
2 |
3 |
||||
Current Year |
Prior Year |
Prior Year Ended |
||||
To Date |
To Date |
|
||||
1. |
Cash from Operations |
|||||
Premiums collected net of reinsurance |
(3,244,178) |
(450,582) |
283,606 |
|||
2. |
Net investment income |
336,798 |
411,380 |
578,180 |
||
3. |
Miscellaneous income |
65,598 |
74,608 |
|||
4. |
Total (Lines 1 to 3) |
(2,841,782) |
(39,202) |
936,394 |
||
5. |
Benefit and loss related payments |
32,410 |
1,817,147 |
(269,384) |
||
6. |
Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts |
|||||
7. |
Commissions, expenses paid and aggregate write-ins for deductions |
1,271,891 |
967,622 |
990,759 |
||
8. |
Dividends paid to policyholders |
|||||
9. |
Federal and foreign income taxes paid (recovered) net of $ |
0 tax on capital |
||||
10. |
gains (losses) |
32,204 |
(81,009) |
|||
Total (Lines 5 through 9) |
1,336,505 |
2,784,769 |
640,366 |
|||
11. |
Net cash from operations (Line 4 minus Line 10) |
(4,178,287) |
(2,823,971) |
296,028 |
||
12. |
Cash from Investments |
|||||
Proceeds from investments sold, matured or repaid: |
||||||
12.1 |
Bonds |
850,000 |
||||
12.2 |
Stocks |
|||||
12.3 |
Mortgage loans |
|||||
12.4 |
Real estate |
|||||
12.5 |
Other invested assets |
|||||
12.6 |
Net gains or (losses) on cash, cash equivalents and short-term investments |
|||||
12.7 |
Miscellaneous proceeds |
|||||
13. |
12.8 |
Total investment proceeds (Lines 12.1 to 12.7) |
850,000 |
|||
Cost of investments acquired (long-term only): |
||||||
13.1 |
Bonds |
838,084 |
||||
13.2 |
Stocks |
|||||
13.3 |
Mortgage loans |
|||||
13.4 |
Real estate |
|||||
13.5 |
Other invested assets |
|||||
13.6 |
Miscellaneous applications |
|||||
14. |
13.7 |
Total investments acquired (Lines 13.1 to 13.6) |
838,084 |
|||
Net increase/(decrease) in contract loans and premium notes |
||||||
15. |
Net cash from investments (Line 12.8 minus Line 13.7 and Line 14) |
11,916 |
||||
16. |
Cash from Financing and Miscellaneous Sources |
|||||
Cash provided (applied): |
||||||
16.1 |
Surplus notes, capital notes |
|||||
16.2 |
Capital and paid in surplus, less treasury stock |
|||||
16.3 |
Borrowed funds |
|||||
16.4 |
Net deposits on deposit-type contracts and other insurance liabilities |
|||||
16.5 |
Dividends to stockholders |
|||||
16.6 |
Other cash provided (applied) |
|||||
17. |
Net cash from financing and miscellaneous sources (Line 16.1 through Line 16.4 minus Line 16.5 |
|||||
plus Line 16.6) |
||||||
18. |
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS |
|||||
Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17) |
(4,166,371) |
(2,823,971) |
296,028 |
|||
19. |
Cash, cash equivalents and short-term investments: |
|||||
19.1 |
Beginning of year |
5,727,735 |
5,431,707 |
5,431,707 |
||
19.2 |
End of period (Line 18 plus Line 19.1) |
1,561,364 |
2,607,736 |
5,727,735 |
5
6WDWHPHQWDVRI6HSWHPEHURIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY
127(672),1$1&,$/67$7(0(176 |
Note 1 - Summary of Significant Accounting Policies and Going Concern
- Accounting practices
The financial statements ofPreferred Physicians Medical Risk Retention Group , aMutual Insurance Company (the Company) are presented on the basis of accounting practices prescribed or permitted by theMissouri Department of Commerce and Insurance .
TheMissouri Department of Insurance recognizes only statutory accounting practices prescribed or permitted by theState of Missouri for determining and reporting the financial condition and results of operations of an insurance company, and for determining its solvency under the Missouri Insurance Law.The National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures manual, as amended from time to time, (NAIC SAP) has been adopted as a component of prescribed or permitted practices by theState of Missouri . The Director of Insurance has the right to permit other specific practices that deviate from prescribed practices. There was no difference between NAIC SAP and state permitted practices for either net income or statutory surplus for the quarter endedSeptember 30, 2024 .
A reconciliation of the Company's net income and capital and surplus between NAIC SAP and practices prescribed and permitted byState of Missouri is shown below:
Year-to-date period ended |
||||||||
NET INCOME |
SSAP |
F/S |
F/S |
|
|
|||
# |
Page |
Line # |
2024 |
2023 |
||||
(1) |
State basis (Page 4, Line 20, Columns 1 & 3) |
XXX |
XXX |
XXX |
$ |
- |
$ |
- |
(2) |
State Prescribed Practices that are an increase/ |
- |
- |
|||||
(decrease) from NAIC SAP: |
||||||||
(3) |
State Permitted Practices that are an increase/ |
- |
- |
|||||
(decrease) from NAIC SAP: |
||||||||
(4) |
NAIC SAP (1-2-3=4) |
XXX |
XXX |
XXX |
$ |
- |
$ |
- |
SURPLUS |
||||||||
(5) |
State basis (Page 3, Line 37, Columns 1 & 2) |
XXX |
XXX |
XXX |
$ |
5,000,000 |
$ |
5,000,000 |
(6) |
State Prescribed Practices that are an increase/ |
- |
- |
|||||
(decrease) from NAIC SAP: |
||||||||
(7) |
State Permitted Practices that are an increase/ |
- |
- |
|||||
(decrease) from NAIC SAP: |
||||||||
(8) |
NAIC SAP (5-6-7=8) |
XXX |
XXX |
XXX |
$ |
5,000,000 |
$ |
5,000,000 |
The term "none" or "no significant change" is used in the following notes to indicate that the Company does not have any items requiring disclosure under the respective note.
- Use of estimates in the preparation of the financial statements - No significant change.
- Accounting policy
-
- - (5) No significant change.
-
- Loan-backedsecurities are reported at amortized cost provided that the SVO's designation is 1 or 2. If the SVO's designation is 3 or greater, the security is reported at the lower of amortized cost or fair value. The Company uses the prospective method to make valuation adjustments when necessary.
- - (13) No significant change.
- Going Concern
Management has concluded that there is no doubt regarding the Company's ability to continue as a going concern.
Note 2 - Accounting Changes and Corrections of Errors- None.
Note 3 - Business Combinations and
Note 4 - Discontinued Operations- None.
Note 5 - Investments
- Mortgage loans, including mezzanine real estate loans - None.
- Debt restructuring - None.
- Reverse mortgages - None.
6
6WDWHPHQWDVRI6HSWHPEHURIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY
127(672),1$1&,$/67$7(0(176 |
- Loan-backedsecurities - None.
- Dollar repurchase agreements and/or securities lending transactions - None.
- Repurchase agreements transactions accounted for as secured borrowing - None.
- Reverse repurchase agreements transactions accounted for as secured borrowing - None.
- Repurchase agreements transactions accounted for as a sale - None.
- Reverse repurchase agreements transactions accounted for as a sale - None.
- Real estate - None.
- Low-incomehousing tax credits (LIHTC) - None.
- Restricted assets -
-
- Restricted assets (including pledged)
Gross (Admitted & Nonadmitted) Restricted |
Current Year |
|||||||||||||||||||
Current Year |
Percentage |
|||||||||||||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
||||||||||
G/A |
Total |
Protected |
||||||||||||||||||
Cell |
Admitted |
|||||||||||||||||||
Total |
Supporting |
Protected |
Account |
Total |
Gross |
|||||||||||||||
Protected |
Cell |
Assets |
Increase/ |
Total |
Restricted |
|||||||||||||||
Restricted Asset Category |
General |
Cell |
Account |
Supporting |
Total |
Total From |
Admitted |
Restricted |
to Total |
|||||||||||
Account |
Account |
Restricted |
G/A |
(Decrease) |
Nonadmitted |
Restricted |
to Total |
Admitted |
||||||||||||
(G/A) |
Activity (a) |
Assets |
Activity (b) |
(1 plus 3) |
Prior Year |
(5 minus 6) |
Restricted |
(5 minus 8) |
Assets (c) |
Assets (d) |
||||||||||
a. Subject to contractual |
||||||||||||||||||||
obligation for which |
||||||||||||||||||||
liability is not shown |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
- |
- |
b. Collateral held under |
||||||||||||||||||||
security lending |
||||||||||||||||||||
agreements |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
c. Subject to repurchase |
||||||||||||||||||||
agreements |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
d. Subject to reverse |
||||||||||||||||||||
repurchase agreements |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
e. Subject to dollar |
||||||||||||||||||||
repurchase agreements |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
f. Subject to dollar |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
reverse repurchase |
||||||||||||||||||||
agreements |
||||||||||||||||||||
g. Placed under option |
||||||||||||||||||||
contracts |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
h. Letter stock or |
||||||||||||||||||||
securities restricted as |
||||||||||||||||||||
to sale - excluding FHLB |
||||||||||||||||||||
capital stock |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
i. FHLB capital stock |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
j. On deposit with states |
835,643 |
- |
- |
- |
835,643 |
850,003 |
(14,360) |
- |
$ |
835,643 |
4.0 % |
4.0 % |
||||||||
k. On deposit with other |
||||||||||||||||||||
regulatory bodies |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
l. Pledged as collateral |
||||||||||||||||||||
to FHLB (including |
||||||||||||||||||||
assets backing funding |
||||||||||||||||||||
agreements) |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
m. Pledged as collateral |
||||||||||||||||||||
not captured in other |
||||||||||||||||||||
categories |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
n. Other restricted |
||||||||||||||||||||
assets |
- |
- |
- |
- |
- |
- |
- |
- |
$ |
- |
- |
- |
||||||||
o. Total Restricted |
||||||||||||||||||||
Assets |
$ |
835,643 |
$ |
- |
$ |
- |
$ |
- |
$ |
835,643 |
$ |
850,003 |
$ |
(14,360) |
$ |
- |
$ |
835,643 |
4.0 % |
4.0 % |
- Subset of column 1
- Subset of column 3
- Column 5 divided by Asset Page, Column 1 Line 28
- Column 9 divided by Asset Page, Column 3, Line 28
-
- Detail of assets pledged as collateral not captured in other categories - None.
- Detail of other restricted assets - None.
- Collateral received and reflected as assets within the reporting entity's financial statements - None.
- Working capital finance investments - None.
- Offsetting and netting of assets and liabilities - None.
- 5GI Securities - None.
- Short sales - None.
6.1
6WDWHPHQWDVRI6HSWHPEHURIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY
127(672),1$1&,$/67$7(0(176 |
- Prepayment penalty and acceleration fees - None.
- Reporting entity's share of cash pool by asset type - None.
Note 6 - Joint Ventures, Partnerships and Limited Liability Companies
- Detail for those greater than 10% of admitted assets - None.
- Write-downsfor impairments - None.
Note 7 - Investment Income
- Accrued investment income excluded from surplus - None.
- Amounts nonadmitted - None.
- The gross, nonadmitted and admitted amounts for interest income due and accrued
Interest Income Due and Accrued |
Amount |
||
1. |
Gross |
$ |
18,681 |
2. |
Nonadmitted |
$ |
- |
3. |
Admitted |
$ |
18,681 . |
- The aggregate deferred interest - None.
- The cumulative amounts of paid-in-kind (PIK) interest included in the current principal balance - None.
Note 8 - Derivative Instruments- None.
6.2
6WDWHPHQWDVRI6HSWHPEHURIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY
127(672),1$ |
1&,$/67$7(0(176 |
|||||||||||||||||||||
Note 9 - Income Taxes |
||||||||||||||||||||||
A. The components of the net deferred tax asset/(liability) at |
||||||||||||||||||||||
1. |
Change between years |
|||||||||||||||||||||
|
|
Change |
||||||||||||||||||||
by tax character |
(1) |
(2) |
(3) |
(4) |
(5) |
(6) |
(7) |
(8) |
(9) |
|||||||||||||
(Col 1+2) |
(Col 4+5) |
(Col 1-4) |
(Col 2-5) |
(Col 7+8) |
||||||||||||||||||
Ordinary |
Capital |
Total |
Ordinary |
Capital |
Total |
Ordinary |
Capital |
Total |
||||||||||||||
(a) |
Gross Deferred Tax Assets |
$ |
107,064 |
$ |
- |
$ |
107,064 |
$ |
86,269 |
$ |
- |
$ |
86,269 |
$ |
20,795 |
$ |
- |
$ |
20,795 |
|||
(b) |
Statutory Valuation Allowance |
104,507 |
- |
104,507 |
82,692 |
- |
82,692 |
21,815 |
- |
21,815 |
||||||||||||
Adjustments |
||||||||||||||||||||||
(c) |
Adjusted Gross Deferred Tax |
2,557 |
- |
2,557 |
3,577 |
- |
3,577 |
(1,020) |
- |
(1,020) |
||||||||||||
Assets (1a - 1b) |
||||||||||||||||||||||
(d) |
Deferred Tax Assets |
- |
- |
- |
- |
- |
- |
- |
- |
- |
||||||||||||
Nonadmitted |
||||||||||||||||||||||
(e) |
Subtotal Net Admitted |
2,557 |
- |
2,557 |
3,577 |
- |
3,577 |
(1,020) |
- |
(1,020) |
||||||||||||
Deferred Tax Asset (1c - 1d) |
||||||||||||||||||||||
(f) |
Deferred Tax Liabilities |
2,557 |
- |
2,557 |
3,577 |
- |
3,577 |
(1,020) |
- |
(1,020) |
||||||||||||
(g) |
Net Admitted Deferred Tax |
|||||||||||||||||||||
Asset/(Net Deferred Tax |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
||||
Liability)(1e-1f) |
||||||||||||||||||||||
2. |
Admission Calculation |
|||||||||||||||||||||
|
|
Change |
||||||||||||||||||||
Components SSAP No. 101 |
(1) |
(2) |
(3) |
(4) |
(5) |
(6) |
(7) |
(8) |
(9) |
|||||||||||||
(Col 1+2) |
(Col 4+5) |
(Col 1-4) |
(Col 2-5) |
(Col 7+8) |
||||||||||||||||||
Ordinary |
Capital |
Total |
Ordinary |
Capital |
Total |
Ordinary |
Capital |
Total |
- Federal Income Taxes Paid in Prior Years Recoverable
Through Loss Carrybacks |
$ |
2,557 |
$ |
- |
$ |
2,557 |
$ |
- |
$ |
- |
$ |
- |
$ |
2,557 |
$ |
- |
$ |
2,557 |
|
(b) Adjusted Gross Deferred Tax |
|||||||||||||||||||
Assets Expected To Be |
|||||||||||||||||||
Realized (Lesser of 2(b)1 and |
|||||||||||||||||||
2(b)2 Below) |
$ |
- |
$ |
- |
$ |
- |
$ |
3,577 |
$ |
- |
$ |
3,577 |
$ |
(3,577) |
$ |
- |
$ |
(3,577) |
|
1. |
Adjusted Gross Deferred |
||||||||||||||||||
Tax Assets Expected To |
|||||||||||||||||||
Be Realized Following the |
$ |
- |
$ |
- |
$ |
- |
$ |
3,577 |
$ |
- |
$ |
3,577 |
$ |
(3,577) |
$ |
- |
$ |
(3,577) |
|
Balance Sheet Date |
|||||||||||||||||||
2. |
Adjusted Gross Deferred |
||||||||||||||||||
Tax Assets Allowed per |
XXX |
XXX |
$ |
750,000 |
XXX |
XXX |
$ |
750,000 |
XXX |
XXX |
$ |
- |
|||||||
Limitation Threshold |
|||||||||||||||||||
(c) Adjusted Gross Deferred Tax |
|||||||||||||||||||
Assets Offset by Gross |
|||||||||||||||||||
Deferred Tax Liabilities |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
- Deferred Tax Assets Admitted as the result of application of
SSAP No. 101 |
$ |
2,557 |
$ |
- $ |
2,557 |
$ |
3,577 |
$ |
- $ |
3,577 |
|
$ |
- |
3. Ratio used as basis of admissibility
- Ratio Percentage Used To Determine Recovery Period And Threshold Limitation Amount
- Amount Of Adjusted Capital And Surplus Used To Determine Recovery Period And Threshold Limitation in 2(b)2 Above
|
|
||
485 % |
485 % |
||
$ |
5,000,000 |
$ |
5,000,000 |
4. Impact of tax-planning strategies |
|
|
Change |
||||
(1) |
(2) |
(3) |
(4) |
(5) |
(6) |
||
(Col 1-3) |
(Col 2-4) |
||||||
Ordinary |
Capital |
Ordinary |
Capital |
Ordinary |
Capital |
- Determination Of Adjusted Gross Deferred Tax Assets And Net Admitted Deferred Tax Assets, By Tax Character As A Percentage.
1 Adjusted Gross DTAs Amount From Note 9A1(c) |
$ |
2,557 |
$ |
- $ |
3,577 |
$ |
- $ |
(1,020) |
$ |
- |
2 Percentage Of Adjusted Gross DTAs By Tax Character Attributable To The Impact Of Tax Planning
Strategies |
- |
- |
- |
- |
- |
- |
|
3 |
Net Admitted Adjusted Gross DTAs Amount From |
2,557 |
- |
3,577 |
- |
(1,020) |
- |
Note 9A1(e) |
|||||||
4 |
Percentage Of Net Admitted Adjusted Gross DTAs By |
||||||
Tax Character Admitted Because Of The Impact Of |
- |
- |
- |
- |
- |
- |
|
Tax Planning Strategies |
|||||||
(b) Does the Company's tax-planning strategies include the use of reinsurance? |
No |
B. Deferred Tax Liabilities Not Recognized - None.
6.3
6WDWHPHQWDVRI6HSWHPEHURIWKH3UHIHUUHG3KYVLFLDQV0HGLFDO5LVN5HWHQWLRQ*URXSD0XWXDO,QVXUDQFH&RPSDQY
127(672),1$1&,$/67$7(0(176 |
(1) |
(2) |
(3) |
|||||||||
(Col 1-2) |
|||||||||||
|
|
Change |
|||||||||
1. |
Current Income Tax |
||||||||||
(a) |
Federal |
$ |
32,204 |
$ |
- |
$ |
32,204 |
||||
(b) |
Foreign |
- |
- |
- |
|||||||
(c) |
Subtotal (1a+1b) |
32,204 |
- |
32,204 |
|||||||
(d) |
Federal income tax on net capital gains |
- |
- |
- |
|||||||
(e) |
Utilization of capital loss carry-forwards |
- |
- |
- |
|||||||
(f) |
Other |
- |
18,808 |
(18,808) |
|||||||
(g) |
Federal and foreign income taxes incurred (1c+1d+1e+1f) |
$ |
32,204 |
$ |
18,808 |
$ |
13,396 |
||||
2. |
Deferred Tax Assets: |
||||||||||
(a) |
Ordinary |
||||||||||
(1) |
Discounting of unpaid losses |
$ |
49,667 |
$ |
49,667 |
$ |
- |
||||
(2) |
Unearned premium reserve |
57,397 |
30,987 |
26,410 |
|||||||
(3) |
Policyholder reserves |
- |
- |
- |
|||||||
(4) |
Investments |
- |
- |
- |
|||||||
(5) |
Deferred acquisition costs |
- |
- |
- |
|||||||
(6) |
Policyholder dividends accrual |
- |
- |
- |
|||||||
(7) |
Fixed assets |
- |
- |
- |
|||||||
(8) |
Compensation and benefits accrual |
- |
- |
- |
|||||||
(9) |
Pension accrual |
- |
- |
- |
|||||||
(10) |
Receivables - nonadmitted |
- |
- |
- |
|||||||
(11) |
Net operating loss carry-forward |
- |
5,615 |
(5,615) |
|||||||
(12) |
Tax credit carry-forward |
- |
- |
- |
|||||||
(13) |
Other |
- |
- |
- |
|||||||
(99) Subtotal (sum of 2a1 through 2a13) |
$ |
107,064 |
$ |
86,269 |
$ |
20,795 |
|||||
(b) |
Statutory valuation allowance adjustment |
104,507 |
82,692 |
21,815 |
|||||||
(c) |
Nonadmitted |
- |
- |
- |
|||||||
(d) |
Admitted ordinary deferred tax assets (2a99 - 2b - 2c) |
$ |
2,557 |
$ |
3,577 |
$ |
(1,020) |
||||
(e) |
Capital |
||||||||||
(1) |
Investments |
$ |
- |
$ |
- |
$ |
- |
||||
(2) |
Net capital loss carry-forward |
- |
- |
- |
|||||||
(3) |
Real estate |
- |
- |
- |
|||||||
(4) |
Other |
- |
- |
- |
|||||||
(99) Subtotal (2e1+2e2+2e3+2e4) |
$ |
- |
$ |
- |
$ |
- |
|||||
(f) |
Statutory valuation allowance adjustment |
- |
- |
- |
|||||||
(g) |
Nonadmitted |
- |
- |
- |
|||||||
(h) |
Admitted capital deferred tax assets (2e99 - 2f - 2g) |
$ |
- |
$ |
- |
$ |
- |
||||
(i) |
Admitted deferred tax assets (2d + 2h) |
$ |
2,557 |
$ |
3,577 |
$ |
(1,020) |
||||
3. |
Deferred Tax Liabilities: |
||||||||||
(a) |
Ordinary |
||||||||||
(1) |
Investments |
$ |
243 |
$ |
- |
$ |
243 |
||||
(2) |
Fixed assets |
- |
- |
- |
|||||||
(3) |
Deferred and uncollected premium |
- |
- |
- |
|||||||
(4) |
Policyholder reserves |
- |
- |
- |
|||||||
(5) |
Other |
2,314 |
3,577 |
(1,263) |
|||||||
(99) Subtotal (3a1+3a2+3a3+3a4+3a5) |
$ |
2,557 |
$ |
3,577 |
$ |
(1,020) |
|||||
(b) |
Capital |
||||||||||
(1) |
Investments |
$ |
- |
$ |
- |
$ |
- |
||||
(2) |
Real estate |
- |
- |
- |
|||||||
(3) |
Other |
- |
- |
- |
|||||||
(99) Subtotal (3b1+3b2+3b3) |
$ |
- |
$ |
- |
$ |
- |
|||||
(c) |
Deferred tax liabilities (3a99 + 3b99) |
||||||||||
$ |
2,557 |
$ |
3,577 |
$ |
(1,020) |
||||||
4. |
Net deferred tax assets/liabilities (2i - 3c) |
$ |
- $ |
- $ |
- |
||||||
6.4
Attachments
Disclaimer
"ProAssurance America Mutual A Risk Retention Group","PNC QS","2024 09 30" Annual Statutory Statement
RI is close to eliminating new HIV infections. Why an insurer's decision could change that
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News